Remdesivir for Injection recall in Canada: medication error risk
In plain language
This recall involves US clinical trial-labelled Remdesivir for Injection sold in Canada. It's being recalled because the labelling is incomplete and could lead to medication errors. Healthcare professionals should use the Canadian Product Monograph for full information.
What to do
- Stop using the product if you are a healthcare professional and are not aware of the specific instructions.
- Refer to the Canadian Product Monograph for complete product information.
- Disregard statements on the vial label like "For Clinical Trial Use Only."
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Remdesivir for Injection, powder for solution for infusion, 100 mg/vial (5 mg/mL when reconstituted) US clinical trial-labelled
Why this matters
Medication error risk due to incomplete labelling
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Medication error risk due to incomplete labelling
What should consumers do?
Stop using the product if you are a healthcare professional and are not aware of the specific instructions. Refer to the Canadian Product Monograph for complete product information. Disregard statements on the vial label like "For Clinical Trial Use Only."
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Medication error risk due to incomplete labelling
When was this product recalled?
This product was recalled on September 15, 2020.
Is the Remdesivir brand affected by this recall?
Yes, Remdesivir products are affected by this recall. This recall involves US clinical trial-labelled Remdesivir for Injection sold in Canada. It's being recalled because the labelling is incomplete and could lead to medication errors. Healthcare professionals should use the Canadian Product Monograph for full information.